Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
6MW3211 / Mabwell (Shanghai) Biosci
NCT05431569: A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung Cancer	Not yet recruiting	2a	36	NA	6MW3211, 6MW3211injection	Mabwell (Shanghai) Bioscience Co., Ltd.	Advanced Lung Cancer	12/22	09/23
NCT05440045: A Clinical Study of 6MW3211 in Patients With Renal Cancer	Not yet recruiting	2	30	NA	6MW3211, 6MW3211 injection	Mabwell (Shanghai) Bioscience Co., Ltd.	Advanced Clear Cell Renal Cell Carcinoma	01/24	09/24
NCT05446688: A Clinical Study of 6MW3211 Injection in the Treatment of Relapsed/Refractory Lymphoma	Not yet recruiting	2	40	NA	6MW3211	Mabwell (Shanghai) Bioscience Co., Ltd.	Lymphoma	03/24	09/24
NCT05048160: A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm	Recruiting	1/2	272	RoW	Intravenous Infusion	Mabwell (Shanghai) Bioscience Co., Ltd.	Advanced Malignant Neoplasm	06/24	12/24
NCT05448599: A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS	Recruiting	1/2	120	RoW	6MW3211 injection with Intravenous Infusion, infusion	Mabwell (Shanghai) Bioscience Co., Ltd.	Acute Myeloid Leukemia, Myelodysplastic Syndrome	06/24	10/24